Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Current Leases (2019 - 2022)

Edesa Biotech's Current Leases history spans 4 years, with the latest figure at $40123.0 for Q2 2022.

  • For Q2 2022, Current Leases fell 49.53% year-over-year to $40123.0; the TTM value through Jun 2022 reached $40123.0, down 49.53%, while the annual FY2021 figure was $78808.0, 13.02% up from the prior year.
  • Current Leases for Q2 2022 was $40123.0 at Edesa Biotech, down from $61541.0 in the prior quarter.
  • Across five years, Current Leases topped out at $80167.0 in Q4 2021 and bottomed at $40123.0 in Q2 2022.
  • The 4-year median for Current Leases is $69730.0 (2020), against an average of $68890.6.
  • The largest annual shift saw Current Leases rose 22.83% in 2021 before it plummeted 49.53% in 2022.
  • A 4-year view of Current Leases shows it stood at $66631.0 in 2019, then grew by 12.38% to $74877.0 in 2020, then grew by 7.06% to $80167.0 in 2021, then tumbled by 49.95% to $40123.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Current Leases are $40123.0 (Q2 2022), $61541.0 (Q1 2022), and $80167.0 (Q4 2021).